ArticleFrontiers in immunology2023

ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma.

Catrin Heim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.